Gadolinium (III)‐Chelated Deformable Mesoporous Organosilica Nanoparticles as Magnetic Resonance Imaging Contrast Agent
Advanced Materials · 2023-05 · 35 (20)
DOI: 10.1002/adma.202211578 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 02.04.2023. Verfasst von Xiangyu Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Life and Health Intelligent Research Institute, Tianjin University of Technology, Tianjin, 300384, P. R. China. Hauptthemen laut MEDLINE: Contrast Media, Nanoparticles. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Chinese Academy of Sciences.
Abstract (Originalsprache)
Magnetic resonance imaging (MRI) contrast agents, such as Magnevist (Gd‐DTPA), are routinely used for detecting tumors at an early stage. However, the rapid clearance by the kidney of Gd‐DTPA leads to short blood circulation time, which limits further improvement of the contrast between tumorous and normal tissue. Inspired by the deformability of red blood cells, which improves their blood circulation, this work fabricates a novel MRI contrast agent by incorporating Gd‐DTPA into deformable mesoporous organosilica nanoparticles (D‐MON). In vivo distribution shows that the novel contrast agent is able to depress rapid clearance by the liver and spleen, and the mean residence time is 20 h longer than Gd‐DTPA. Tumor MRI studies demonstrated that the D‐MON‐based contrast agent is highly enriched in the tumor tissue and achieves prolonged high‐contrast imaging. D‐MON significantly improves the performance of clinical contrast agent Gd‐DTPA, exhibiting good potential in clinical applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Life and Health Intelligent Research Institute, Tianjin University of Technology, Tianjin, 300384, P. R. China.
- State Key Laboratory of Inorganic Synthesis and Preparative Chemistry, College of Chemistry, Jilin University, Changchun, 130022, P. R. China.
- Beijing National Laboratory for Molecular Sciences, Key Laboratory of Analytical Chemistry for Living Biosystems, Institute of Chemistry, Chinese Academy of Sciences CAS, Beijing, 100049, P. R. China.
- NHC Key Laboratory of Human Disease Comparative Medicine, Institute of Laboratory Animal Sciences, Peking Union Medicine College, Chinese Academy of Medical Sciences, Beijing, 100021, P. R. China.
- Center of Digital Dentistry, Peking University School and Hospital of Stomatology NHC Research Center of Engineering and Technology for Computerized Dentistry, Beijing, 100081, P. R. China.
ORCID-Profile: Xiangyu Chen, Tie Wang
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- Chinese Academy of Sciences
- China Postdoctoral Science Foundation
Zitieren
APA
Chen, X., Teng, S., Li, J., Qiao, X., Zhao, W., Xue, Z., Shi, X., Wang, Y., Yang, W., & Wang, T. (2023). Gadolinium (III)‐Chelated Deformable Mesoporous Organosilica Nanoparticles as Magnetic Resonance Imaging Contrast Agent. Advanced Materials, 35(20). https://doi.org/10.1002/adma.202211578
Vancouver
Chen X, Teng S, Li J, Qiao X, Zhao W, Xue Z, et al. Gadolinium (III)‐Chelated Deformable Mesoporous Organosilica Nanoparticles as Magnetic Resonance Imaging Contrast Agent. Advanced Materials. 2023;35(20). doi:10.1002/adma.202211578
BibTeX
@article{Chen2023,
author = {Chen, Xiangyu and Teng, Shiyong and Li, Jinming and Qiao, Xuezhi and Zhao, Weidong and Xue, Zhengjie and Shi, Xudong and Wang, Yuguang and Yang, Wensheng and Wang, Tie},
title = {Gadolinium (III)‐Chelated Deformable Mesoporous Organosilica Nanoparticles as Magnetic Resonance Imaging Contrast Agent},
journal = {Advanced Materials},
year = {2023},
volume = {35},
number = {20},
doi = {10.1002/adma.202211578}
}
EUVIMED